ELECTRONIC ARTICLE |






* National Institutes of Health, Bethesda, Maryland
Infusion Nurses Society, Cambridge, Massachusetts
University of Washington, Seattle, Washington
|| Office of the Director, CDC, Atlanta, Georgia
¶ University of Massachusetts Medical School, Worcester, Massachusetts
# University of Wisconsin Medical School, Madison, Wisconsin
** University of Wisconsin Hospital and Clinics, Madison, Wisconsin

Rhode Island Hospital and Brown University School of Medicine, Providence, Rhode Island

Division of Healthcare Quality Promotion, National Center for Infectious Diseases Centers for Disease Control and Prevention, Atlanta, Georgia
|||| M. D. Anderson Cancer Center, Houston, Texas
¶¶ The Childrens Hospital, Boston, Massachusetts
## Cook County Hospital and Rush Medical College, Chicago, Illinois
These guidelines have been developed for practitioners who insert catheters and for persons responsible for surveillance and control of infections in hospital, outpatient, and home health-care settings. This report was prepared by a working group comprising members from professional organizations representing the disciplines of critical care medicine, infectious diseases, health-care infection control, surgery, anesthesiology, interventional radiology, pulmonary medicine, pediatric medicine, and nursing. The working group was led by the Society of Critical Care Medicine (SCCM), in collaboration with the Infectious Disease Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), Surgical Infection Society (SIS), American College of Chest Physicians (ACCP), American Thoracic Society (ATS), American Society of Critical Care Anesthesiologists (ASCCA), Association for Professionals in Infection Control and Epidemiology (APIC), Infusion Nurses Society (INS), Oncology Nursing Society (ONS), Society of Cardiovascular and Interventional Radiology (SCVIR), American Academy of Pediatrics (AAP), and the Healthcare Infection Control Practices Advisory Committee (HICPAC) of the Centers for Disease Control and Prevention (CDC) and is intended to replace the Guideline for Prevention of Intravascular Device-Related Infections published in 1996. These guidelines are intended to provide evidence-based recommendations for preventing catheter-related infections. Major areas of emphasis include 1) educating and training health-care providers who insert and maintain catheters; 2) using maximal sterile barrier precautions during central venous catheter insertion; 3) using a 2% chlorhexidine preparation for skin antisepsis; 4) avoiding routine replacement of central venous catheters as a strategy to prevent infection; and 5) using antiseptic/antibiotic impregnated short-term central venous catheters if the rate of infection is high despite adherence to other strategies (ie, education and training, maximal sterile barrier precautions, and 2% chlorhexidine for skin antisepsis). These guidelines also identify performance indicators that can be used locally by health-care institutions or organizations to monitor their success in implementing these evidence-based recommendations.
Key Words: catheter-related bloodstream infections intensive care unit central venous catheter peripherally inserted central catheter guidelines
Abbreviations: CRBSI, catheter-related bloodstream infections HICPAC, Healthcare Infection Control Practices Advisory Committee CDC, Centers for Disease Control and Prevention ICU, intensive care unit BSI, bloodstream infection CVC, central venous catheter PICC, peripherally inserted central catheter NNIS, National Nosocomial Infection Surveillance RR, relative risk CI, confidence interval IV, intravenous FDA, US Food and Drug Administration VRE, vancomycin-resistant enterococcus VCH, vancomycin/ciprofloxacin/heparin VH, vancomycin/heparin
This article has been cited by other articles:
![]() |
S. L. Bratton Decreasing Catheter-Related Bloodstream Infections in the ICU AAP Grand Rounds, March 1, 2007; 17(3): 27 - 27. [Full Text] [PDF] |
||||
![]() |
A. Bhutta, C. Gilliam, M. Honeycutt, S. Schexnayder, J. Green, M. Moss, and K J S Anand Reduction of bloodstream infections associated with catheters in paediatric intensive care unit: stepwise approach BMJ, February 17, 2007; 334(7589): 362 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Casey, T. Worthington, P. A. Lambert, and T. S. J. Elliott Evaluation of routine microbiological techniques for establishing the diagnosis of catheter-related bloodstream infection caused by coagulase-negative staphylococci J. Med. Microbiol., February 1, 2007; 56(2): 172 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sass and G. Bierbaum Lytic Activity of Recombinant Bacteriophage {phi}11 and {phi}12 Endolysins on Whole Cells and Biofilms of Staphylococcus aureus Appl. Envir. Microbiol., January 1, 2007; 73(1): 347 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schilling, D. Doellman, N. Hutchinson, and B. R. Jacobs The Impact of Needleless Connector Device Design on Central Venous Catheter Occlusion in Children: A Prospective, Controlled Trial JPEN J Parenter Enteral Nutr, March 1, 2006; 30(2): 85 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Chwals Vascular Access for Home Intravenous Therapy in Children JPEN J Parenter Enteral Nutr, January 1, 2006; 30(1_suppl): S65 - S69. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Bratton Catheter-Related Blood Infections in the ICU AAP Grand Rounds, January 1, 2004; 11(1): 9 - 9. [Full Text] [PDF] |
||||
![]() |
J. A. Wu, C. Kusuma, J. J. Mond, and J. F. Kokai-Kun Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial Surfaces Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3407 - 3414. [Abstract] [Full Text] [PDF] |
||||